查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542479

全球生物样本库市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Biobanking Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 285 Pages | 商品交期: 最快1-2个工作天内

价格

全球生物样本库市场需求预计将从 2023 年的 578 亿美元增至 2032 年的近 993.3 亿美元，2024-2032 年研究期间复合年增长率为 6.2%。

生物样本库是指生物样本和健康资讯的集合。不同的生物样本库收集不同类型的资讯和样本，有些是特定于特定疾病或特定研究的，而有些是基于人群的。收集的样本与描述样本历史、采样方法、样本处理和分析结果的资料清单相关联，并用于开发新疗法或新技术和科学出版物。生物库有多种类型：以疾病为中心、基于人群、DNA/RNA、组织与多个样本类型、商业、项目驱动和虚拟生物库。

市场动态

医疗保健领域不断增长的临床试验和研究以及研究人员不断变化的需求预计将推动市场的发展。生物样本库正在发展成为一个潜在领域，因为精确和准确的结果收集在众多研究中发挥着重要作用。这种不断发展的增长是由基因组学、蛋白质组学和个人化医疗领域不断发展的研究提供的。生物样本库中专门用于伴随诊断和生物标记的样本数量大幅增加。为了满足不断增长的需求，生物样本库和组织供应商的规模和数量都呈指数级增长，目前正在成为学术和商业团体的重要合作伙伴。同时，与生物样本样本采购和自动化成本高相关的问题正在阻碍市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球生物样本库市场的每个细分市场进行了包容性评估。生物样本库产业的成长和趋势为本研究提供了整体方法。

市场区隔

生物样本库市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 装置
  • 耗材
  • 软体与服务

依生物样本类型

  • 血液製品
  • 人体组织
  • 细胞系
  • 核酸
  • 其他的

按申请

  • 疗法
  • 临床诊断
  • 药物发现与开发
  • 其他的

依储存类型

  • 手动的
  • 自动化

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲生物样本库市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物样本库市场的主要参与者包括Thermo Fisher Scientific Inc.、Tecan Group Ltd.、Qiagen NV、Hamilton Company、Brooks Automation、TTP Labtech Ltd.、VWR Corporation、Promega Corporation、Worthington Industries、Chart Industries、Becton、Dickinson And Company ，默克公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：生物银行 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按生物样本类型进行的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按储存类型分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球生物银行市场分析：按产品

  • 概述（按产品）
  • 历史和预测数据
  • 按产品分析
  • 装置
  • 耗材
  • 软体与服务

第 6 章：全球生物银行市场分析：依生物样本类型

  • 依生物样本类型概述
  • 历史和预测数据
  • 依生物样本类型进行分析
  • 血液製品
  • 人体组织
  • 细胞系
  • 核酸
  • 其他的

第 7 章：全球生物银行市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 疗法
  • 临床诊断
  • 药物发现与开发
  • 其他的

第 8 章：全球生物银行市场分析：按储存类型

  • 按储存类型概述
  • 历史和预测数据
  • 按储存类型分析
  • 手动的
  • 自动化

第 9 章：全球生物银行市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：生物银行公司的竞争格局

  • 生物样本库市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Tecan Group Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Qiagen NV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Hamilton Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Brooks Automation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • TTP Labtech Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • VWR Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Promega Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Worthington Industries
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chart Industries
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Becton
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Dickinson And Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11212372

The global demand for Biobanking Market is presumed to reach the market size of nearly USD 99.33 Billion by 2032 from USD 57.8 Billion in 2023 with a CAGR of 6.2% under the study period 2024-2032.

Biobanking refers to a collection of biological samples and health information. Different biobank collects different types of information and samples some are specific to a particular disease or specific research while some are population based. The collected samples are associated with a list of data describing sample history, sampling method, sample treatment, and the analysis outcomes and are used for the development of new treatments or new technologies and scientific publications. There are several types of biobanks: disease-centric, population-based, DNA/RNA, tissue versus multiple specimen type, commercial, project-driven, and virtual biobanks.

MARKET DYNAMICS

Growing clinical trials and research in the healthcare and changing needs of investigators is estimated to drive the market. Biobanking is evolving as a potential field as precise and accurate collection of outcomes plays an important role in a multitude of studies. The evolving growth is provided by growing research in the field of genomics, proteomics, and personalised medicine. Biobanks have experienced a huge rise in the number of samples specifically requested for companion diagnostic and biomarker. In response to growing demand, biobanks and tissue suppliers have grown exponentially in both size and number, and are now establishing as a key partner for academic and commercial groups. Meanwhile, issues associated with biospecimen sample procurement and high cost of automation is hampering the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biobanking. The growth and trends of Biobanking industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biobanking market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Equipment
  • Consumables
  • Software & Services

By Biospecimen Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Others

By Application

  • Therapeutics
  • Clinical Diagnostics
  • Drug Discovery & Development
  • Others

By Storage Type

  • Manual
  • Automated

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biobanking market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biobanking market include Thermo Fisher Scientific Inc., Tecan Group Ltd., Qiagen N.V., Hamilton Company, Brooks Automation, TTP Labtech Ltd., VWR Corporation, Promega Corporation, Worthington Industries, Chart Industries, Becton, Dickinson And Company, Merck KGaA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOBANKING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Biospecimen Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Storage Type
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOBANKING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Equipment Historic and Forecast Sales By Regions
  • 5.5. Consumables Historic and Forecast Sales By Regions
  • 5.6. Software & Services Historic and Forecast Sales By Regions

6. GLOBAL BIOBANKING MARKET ANALYSIS BY BIOSPECIMEN TYPE

  • 6.1. Overview By Biospecimen Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Biospecimen Type
  • 6.4. Blood Products Historic and Forecast Sales By Regions
  • 6.5. Human Tissues Historic and Forecast Sales By Regions
  • 6.6. Cell Lines Historic and Forecast Sales By Regions
  • 6.7. Nucleic Acids Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL BIOBANKING MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Therapeutics Historic and Forecast Sales By Regions
  • 7.5. Clinical Diagnostics Historic and Forecast Sales By Regions
  • 7.6. Drug Discovery & Development Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE

  • 8.1. Overview By Storage Type
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Storage Type
  • 8.4. Manual Historic and Forecast Sales By Regions
  • 8.5. Automated Historic and Forecast Sales By Regions

9. GLOBAL BIOBANKING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BIOBANKING COMPANIES

  • 10.1. Biobanking Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF BIOBANKING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Tecan Group Ltd.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Qiagen N.V.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Hamilton Company
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Brooks Automation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. TTP Labtech Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. VWR Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Promega Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Worthington Industries
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Chart Industries
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Becton
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Dickinson And Company
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Merck KGaA
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (Number of Doses (in Thousands) and USD MN)
  • Equipment Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Consumables Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Software & Services Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Analysis By Biospecimen Type (Number of Doses (in Thousands) and USD MN)
  • Blood Products Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Human Tissues Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Cell Lines Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Nucleic Acids Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Analysis By Application (Number of Doses (in Thousands) and USD MN)
  • Therapeutics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Clinical Diagnostics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Drug Discovery & Development Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Analysis By Storage Type (Number of Doses (in Thousands) and USD MN)
  • Manual Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Automated Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Biobanking Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • North America Market Analysis (Number of Doses (in Thousands) and USD MN)
  • United States Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Canada Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Mexico Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Europe Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Europe Market Estimate By Country (Number of Doses (in Thousands) and USD MN)
  • United Kingdom Market Analysis (Number of Doses (in Thousands) and USD MN)
  • France Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Germany Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Italy Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Russia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Spain Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Europe Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Asia Pacific Market Analysis (Number of Doses (in Thousands) and USD MN)
  • China Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Japan Market Analysis (Number of Doses (in Thousands) and USD MN)
  • India Market Analysis (Number of Doses (in Thousands) and USD MN)
  • South Korea Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Australia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • South East Asia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Asia Pacific Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Latin America Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Brazil Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Argentina Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Peru Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Chile Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Latin America Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Middle East & Africa Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Saudi Arabia Market Analysis (Number of Doses (in Thousands) and USD MN)
  • UAE Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Israel Market Analysis (Number of Doses (in Thousands) and USD MN)
  • South Africa Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Rest of Middle East and Africa Market Analysis (Number of Doses (in Thousands) and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biobanking Report
  • Market Research Process
  • Market Research Methodology
  • Global Biobanking Market Size, By Region (Number of Doses (in Thousands) and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Biospecimen Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Storage Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (Number of Doses (in Thousands) and USD MN)
  • Equipment Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Consumables Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Software & Services Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Analysis By Biospecimen Type (Number of Doses (in Thousands) and USD MN)
  • Blood Products Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Human Tissues Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Cell Lines Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Nucleic Acids Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Analysis By Application (Number of Doses (in Thousands) and USD MN)
  • Therapeutics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Clinical Diagnostics Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Drug Discovery & Development Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Others Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Analysis By Storage Type (Number of Doses (in Thousands) and USD MN)
  • Manual Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Automated Market Sales By Geography (Number of Doses (in Thousands) and USD MN)
  • Global Market Sales (Number of Doses (in Thousands) and USD MN)
  • North America Market Sales (Number of Doses (in Thousands) and USD MN)
  • Europe Market Sales (Number of Doses (in Thousands) and USD MN)
  • Asia Pacific Market Sales (Number of Doses (in Thousands) and USD MN)
  • Latin America Market Sales (Number of Doses (in Thousands) and USD MN)
  • Middle East & Africa Market Sales (Number of Doses (in Thousands) and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.